As smokers nationwide struggle to quit the habit, St. Jude Children's Research Hospital is offering assistance to those childhood cancer survivors who need help with smoking cessation.
Despite the known health risks of tobacco use, about 18 percent of adults who survived childhood cancer are smokers—an average almost equal to that of the general population. Childhood cancer survivors are more likely to develop second cancers and other conditions such as diabetes, heart disease and stroke. Smoking adds to their health risks.
"The increase in survival rates for childhood cancer has been one of the most significant successes in cancer during the past three decades," said Robert Klesges, Ph.D., of the St. Jude Epidemiology and Cancer Control department. "However, few researchers have addressed the issue of smoking in cancer survivors. Because the population of childhood cancer survivors is growing each year, St. Jude sought an effective way to help these individuals."
In recent years, smoking prevention and cessation efforts in the United States have included public smoking bans, the establishment of toll-free quit lines as well as the Great American Smokeout event organized annually to encourage smokers to quit. This year's event is November 19. To address the unique needs of childhood cancer survivors who smoke, St. Jude created the Cancer Survivor Tobacco Quit Line through a grant from the National Cancer Institute.
Through the quit line, participants are assigned to one of two interventions: a counselor-initiated group or a self-paced group. In the counselor-initiated group, St. Jude counselors call participants six times during an eight-week period. The counselors help participants prepare to quit, set quit dates and help participants avoid relapses. Smokers in the self-paced group receive the same intervention but are responsible for phoning the counselors. All participants receive nicotine-replacement therapy in the form of patches or gum.
"St. Jude has long sought to empower childhood cancer survivors, helping them understand the health risks associated with their treatment as well as providing resources for follow-up care. The quit line is an extension of this philosophy," Klesges said.